Hence, we show ferroptosis induction through glutathione peroxidase 4 (GPX4) inhibition to tumorselectively eliminate mutp53- as well as wtp53-expressing MM cells, paving new avenues for improved MM treatment. The gene discussed is GPX4; the disease is Miyoshi myopathy.